A phase II open label trial evaluating safety andefficacy of a telomerase peptide vaccination inpatients with advanced hepatocellular carcinoma.
Saved in:
| Title: | A phase II open label trial evaluating safety andefficacy of a telomerase peptide vaccination inpatients with advanced hepatocellular carcinoma. |
|---|---|
| Authors: | Greten, Tim F.1,2,3 tim.greten@nih.gov, Forner, Alejandro4, Korangy, Firouzeh1,2,3, N'Kontchou, Gisele5, Barget, Nathalie5, Ayuso, Carmen4, Ormandy, Lars A.1,6, Manns, Michael P.1, Beaugrand, Michel5, Bruix, Jordi4 jbruix@clinic.ub.es |
| Source: | BMC Cancer. 2010, Vol. 10, p209-215. 7p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
